MariMed Inc.
MRMD
$0.07
$0.000.14%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 39.48M | 41.65M | 40.76M | 39.61M | 37.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.48M | 41.65M | 40.76M | 39.61M | 37.91M |
| Cost of Revenue | 24.21M | 31.15M | 24.40M | 23.58M | 22.82M |
| Gross Profit | 15.28M | 10.50M | 16.36M | 16.03M | 15.09M |
| SG&A Expenses | 14.98M | 14.94M | 14.62M | 14.75M | 15.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.19M | 46.09M | 39.02M | 38.33M | 38.70M |
| Operating Income | 294.00K | -4.44M | 1.74M | 1.28M | -798.00K |
| Income Before Tax | -1.12M | -7.33M | -182.00K | -579.00K | -2.65M |
| Income Tax Expenses | 2.65M | -2.69M | 2.76M | 691.00K | 2.83M |
| Earnings from Continuing Operations | -3.77M | -4.64M | -2.94M | -1.27M | -5.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -18.00K | 10.00K | -7.00K | 1.00K | -32.00K |
| Net Income | -3.79M | -4.63M | -2.95M | -1.27M | -5.51M |
| EBIT | 294.00K | -4.44M | 1.74M | 1.28M | -798.00K |
| EBITDA | 3.70M | -1.55M | 4.53M | 4.36M | 2.28M |
| EPS Basic | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 397.45M | 395.30M | 392.61M | 389.90M | 382.56M |
| Average Diluted Shares Outstanding | 397.45M | 395.30M | 392.61M | 389.90M | 382.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |